Business

• Burrill Addresses State of the Industry
  Podcast: May 15, 2009
• Calling it Quits by MARIE DAGHLIAN
  As tough times continue for small biotech, several ready to throw in the towel.
• Brave New Biotech World by Peter Winter
  With the global economic crisis and healthcare reform, life sciences companies must adapt to thrive. Here are five strategies for success.

Health

• Building A Bigger Brain
  Study shows that meditation may increase gray matter.
• Just Say “No”
  Critics of widespread practice say providing free drug samples to patients risks harm to public health.
• Phoning It In
  New reports suggest using videoconferencing to evaluate stroke patients can be just as effective as a bedside exam.

Magazine

• 
  August/September 2008
• 
  June/July 2008 edition

Policy / Law

• Eighty-Sixing Free Speech by PETER J. PITTS
  European Court of Justice ruling will having chilling effect on providing information about pharmaceuticals.
• Money for Nothing by Peter J. Pitts
  Obama’s budget requested for drug regulators is good, but money for drug importation is money wasted.
• Largely Verboten
  Direct-to-consumer genetic tests are restricted in Germany.

Society

• Underfunded, Understaffed, and No Oversight
  “Badly fragmented” forensic science system needs overhaul.
• Protecting Historic Treasures
  Scientists team with curators to stem decay of world's art, cultural heritage.
• Race Matters
  Study finds African-Americans more distrusting of research than whites.

Tech/Innovation

• Predicting Alzheimer’s
  A 15-point risk index can help predict likelihood of an elderly person developing the neurodegenerative disease.
• Too Close for Comfort
  Review finds conflicts of interest in many cancer studies.
• Picturing Austism
  Imaging study finds evidence of brain abnormalities in toddlers with the disorder.